Episodes
Wednesday Sep 01, 2021
29: SPECIAL EDITION: Insulin Biosimilars Part 1
Wednesday Sep 01, 2021
Wednesday Sep 01, 2021
This special edition episode is brought to you by AmerisourceBergen’s Insights podcast. In part one of a two-part series on insulin biosimilars, host, Jennifer Kemper, Director of Content Strategy, speaks with Sean McGowan, Senior Director of Biosimilars, Michelle Jesse, Director of Biosimilar Commercialization, and Brad Tallamy, Senior Director of Government Affairs, about what these new drugs could mean for the category. They’ll discuss how and why insulins are in the biosimilar category, how congress is approaching biosimilars, and if an interchangeability status is on the horizon.
Be on the lookout for part two! Our host and guests stay on the topic of insulin biosimilars and discuss how pharmacies can prepare for interchangeability.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.